Clinical Study

Effectiveness of a Novel Device in the Reduction of Cesarean Deliveries

Table 1

(Efforts to manage the cesarean delivery rate) baseline information by treatment. Efficacy population.

SummaryTreatment groupP value
HEM-AVERTControl

Number of patients 50 48
Weight (lbs)
N 50480.61881
 Mean (SD)180.6 (44.46)183.2 (43.79)
 Median171.5174.0
 Min, max108, 305122, 350
Age
N 50480.71921
 Mean (SD)25.0 (5.29)25.0 (6.24)
 Median26.024.0
 Min, max14, 3616, 41
Previous births 30 (60.0%) 23 (47.9%) 0.31082
Number of previous cesareans
 048 (96.0%)46 (95.8%)0.96693
 12 (4.0%)2 (4.2%)
Number of previous vaginal births
 020 (40.0%)25 (52.1%)0.35013
 115 (30.0%)11 (22.9%)
 26 (12.0%)4 (8.3%)
 36 (12.0%)4 (8.3%)
 42 (4.0%)2 (4.2%)
 51 (2.0%)0
 602 (4.2%)

Statistical Method:
1Wilcoxon-Rank Sum test.
2Fisher’s Exact test.
3Cochran-Mantel-Haenszel test.